An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis
Icahn School of Medicine at Mount Sinai · Austrian Academy of Sciences · +12 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
175
total citations
- FWCI
- 27.17
- Percentile
- 100%
- References
- 61
Citations per year
Authors
38- NMNelson M. LaMarcheCorresponding
Icahn School of Medicine at Mount Sinai
- SHSamarth Hegde
Icahn School of Medicine at Mount Sinai
- MDMatthew D. Park
Icahn School of Medicine at Mount Sinai
- BMBárbara Maier
Austrian Academy of Sciences, CeMM Research Center for Molecular Medicine, Icahn School of Medicine at Mount Sinai
- LTLeanna Troncoso
Icahn School of Medicine at Mount Sinai
Topics & keywords
Topics
Keywords
- Myelopoiesis
- Myeloid
- Cancer research
- Immunology
- Bone marrow
- CD8
- Medicine
- Immune system
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- CRCancer Research InstituteAward: CRI3617
- BSBristol-Myers Squibb
- AAstraZeneca
- CCelgene
- ISIcahn School of Medicine at Mount Sinai
- RPRegeneron Pharmaceuticals
- CTCelldex Therapeutics
- ABAtara Biotherapeutics
- MTMirati Therapeutics
- GTG1 Therapeutics
- GPGlenmark Pharmaceuticals
- APAstellas Pharma
- NINational Institutes of HealthAwards: CA154947, CA263705, DK124165, CA224319, CA196521
- GGenentech
- NCNational Cancer InstituteAwards: CA254104, K00 CA223043, U01CA282114, CA196521, CA154947, DK124165, CA257195, CA224319